Shaklai M - Search Results

1

BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation.

Blickstein D, Aviram A, Luboshitz J, Prokocimer M, Stark P, Bairey O, Sulkes J, Shaklai M. Blickstein D, et al. Among authors: shaklai m. Blood. 1997 Oct 1;90(7):2768-71. Blood. 1997. PMID: 9326244 Free article.

2

Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients.

Aviram A, Blickstein D, Stark P, Luboshitz J, Bairey O, Prokocimer M, Shaklai M. Aviram A, et al. Among authors: shaklai m. Leuk Lymphoma. 1999 Mar;33(1-2):77-82. doi: 10.3109/10428199909093727. Leuk Lymphoma. 1999. PMID: 10194123 Review.

3

Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.

Shaklai S, Bairey O, Blickstein D, Prokocimer M, Hadar H, Lahav M, Sulkes J, Shaklai M. Shaklai S, et al. Among authors: shaklai m. Cancer. 1996 Jun 1;77(11):2313-7. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2313::AID-CNCR20>3.0.CO;2-Z. Cancer. 1996. PMID: 8635101 Clinical Trial.

4

Serum CA 125 levels in patients with chronic lymphocytic leukemia.

Bairey O, Shaklai M. Bairey O, et al. Among authors: shaklai m. Clin Lab Haematol. 2005 Feb;27(1):57-60. doi: 10.1111/j.1365-2257.2004.00656.x. Clin Lab Haematol. 2005. PMID: 15686509

5

Haemarthrosis in patients with mild coagulation factor deficiency.

Bairey O, Shaklai M, Inbal A. Bairey O, et al. Among authors: shaklai m. Blood Coagul Fibrinolysis. 1991 Oct;2(5):669-71. doi: 10.1097/00001721-199110000-00014. Blood Coagul Fibrinolysis. 1991. PMID: 1782338

6

Human T lymphotropic virus type 1 in a seronegative B chronic lymphocytic leukemia patient.

Stark P, Bodemer W, Hannig H, Luboshitz J, Shaklai M, Shohat B. Stark P, et al. Among authors: shaklai m. Med Microbiol Immunol. 2003 Nov;192(4):205-9. doi: 10.1007/s00430-002-0169-3. Epub 2003 Jan 9. Med Microbiol Immunol. 2003. PMID: 14615889

7

Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.

Bairey O, Gabbay U, Blickstein D, Stark P, Prokocimer M, Epstein O, Shaklai M, Lahav J. Bairey O, et al. Among authors: shaklai m. Hematol Oncol. 1997 Aug;15(3):121-7. doi: 10.1002/(sici)1099-1069(199708)15:3<121::aid-hon606>3.0.co;2-d. Hematol Oncol. 1997. PMID: 9600111

8

Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease.

Aviram A, Rabizadeh E, Zimra Y, Yeshoron M, Marmelstein M, Shaklai M, Bairey O. Aviram A, et al. Among authors: shaklai m. Eur J Haematol. 2000 Feb;64(2):80-4. doi: 10.1034/j.1600-0609.2000.90042.x. Eur J Haematol. 2000. PMID: 10997327

9

Relapse of aggressive myeloma after complete remission in secondary acute leukemia: coincidence or consequence?

Bairey OS, Sandbank Y, Shaklai M. Bairey OS, et al. Among authors: shaklai m. Leuk Lymphoma. 1993 Dec;12(1-2):147-51. doi: 10.3109/10428199309059584. Leuk Lymphoma. 1993. PMID: 8161931

10

[Relapse of multiple myeloma in extramedullary sites].

Bairey O, Huminer D, Blickstein D, Sandbank Y, Shaklai M. Bairey O, et al. Among authors: shaklai m. Harefuah. 1993 May 2;124(9):539-41, 600. Harefuah. 1993. PMID: 8340001 Hebrew.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters